These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12009243)

  • 1. Second-line chemotherapy for non-small cell lung cancer: is more better or just simply more?
    Shepherd FA
    Lung Cancer; 2002 Jun; 36(3):309-11. PubMed ID: 12009243
    [No Abstract]   [Full Text] [Related]  

  • 2. [Docetaxel].
    Takigawa N
    Nihon Rinsho; 2002 May; 60 Suppl 5():349-52. PubMed ID: 12101686
    [No Abstract]   [Full Text] [Related]  

  • 3. Study shows 2-year survival advantage for docetaxel.
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):323-4. PubMed ID: 12113094
    [No Abstract]   [Full Text] [Related]  

  • 4. [Carboplatin].
    Watanabe H
    Nihon Rinsho; 2002 May; 60 Suppl 5():366-9. PubMed ID: 12101690
    [No Abstract]   [Full Text] [Related]  

  • 5. Paclitaxel and docetaxel combinations in non-small cell lung cancer.
    Belani CP
    Chest; 2000 Apr; 117(4 Suppl 1):144S-151S. PubMed ID: 10777470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
    Belani CP
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer.
    Oka M; Fukuda M; Nagashima S; Fukuda M; Kinoshita A; Soda H; Doi S; Narasaki F; Suenaga M; Takatani H; Nakamura Y; Kawabata S; Tsurutani J; Kanda T; Kohno S
    Cancer Chemother Pharmacol; 2001 Dec; 48(6):446-50. PubMed ID: 11800024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel (Taxotere) in combination with platinum-based regimens in non-small cell lung cancer: results and future developments.
    Belani CP
    Semin Oncol; 1999 Jun; 26(3 Suppl 10):15-8. PubMed ID: 10437746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel and carboplatin as second-line chemotherapy for metastatic non-small cell lung cancer.
    Laack E; Dierlamm T; Knuffmann C; Popp J; Schmied B; Dürk H; Wacker-Backerhaus G; Zeller W; Verpoort K; Fiedler W; Kurt Hossfeld D
    Lung Cancer; 2002 Jun; 36(3):303-7. PubMed ID: 12009242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of carboplatin and docetaxel for advanced non-small cell lung cancer using the continual reassessment method.
    Kasahara K; Myo S; Iwasa K; Kimura H; Shirasaki H; Yasuda U; Shibata K; Shintani H; Nishi K; Fujimura M; Nakao S
    Jpn J Clin Oncol; 2002 Dec; 32(12):512-6. PubMed ID: 12578899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of docetaxel (Taxotere) in non-small cell lung cancer.
    Kris MG; Miller VA; Ng KK; Grant SC
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-1-S14-4. PubMed ID: 9335515
    [No Abstract]   [Full Text] [Related]  

  • 12. Docetaxel (Taxotere) in combination with platinums in patients with non-small cell lung cancer: trial data and implications for clinical management.
    Belani C; Lynch T
    Semin Oncol; 2001 Feb; 28(1 Suppl 2):10-4. PubMed ID: 11284619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer.
    Kris MG; Millward M
    Semin Oncol; 1999 Jun; 26(3 Suppl 10):1-2. PubMed ID: 10437742
    [No Abstract]   [Full Text] [Related]  

  • 14. New options in the treatment of non-small cell lung cancer.
    Fossella F; Rigas JR; Belani CP
    Anticancer Drugs; 1999 Nov; 10 Suppl 1():S25-8. PubMed ID: 10630365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non--small cell lung cancer: interim analysis.
    Belani C;
    Semin Oncol; 2001 Jun; 28(3 Suppl 9):10-4. PubMed ID: 11441409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taxanes for advanced non-small cell lung cancer.
    Ramalingam S; Belani CP
    Expert Opin Pharmacother; 2002 Dec; 3(12):1693-709. PubMed ID: 12472367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic strategies in advanced non-small cell bronchial cancers: combinations without platin drugs].
    Postmus P
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S48-50. PubMed ID: 12538936
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial.
    Choy H; DeVore RF; Hande KR; Porter LL; Rosenblatt PA; Slovis B; Laporte K; Shyr Y; Johnson DH
    Lung Cancer; 2001 Dec; 34(3):441-9. PubMed ID: 11714542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drug and multimodality combinations in the treatment of advanced non--small cell lung cancer.
    Kawahara M; Kris MG; Green M; Kunitoh H
    Semin Oncol; 2001 Jun; 28(3 Suppl 9):1-4. PubMed ID: 11441408
    [No Abstract]   [Full Text] [Related]  

  • 20. Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer: a phase II study.
    Pectasides D; Visvikis A; Kouloubinis A; Glotsos J; Bountouroglou N; Karvounis N; Ziras N; Athanassiou A
    Eur J Cancer; 2002 Jun; 38(9):1194-200. PubMed ID: 12044505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.